FDA Clearance Tracker · K230528
Extension Set
Last checked: Nov 19, 2026Latest source record: Dec 1, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Dec 1, 2023
Substantially Equivalent
Time to decision
277 days
Received Feb 27, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K230528
- Device name
- Extension Set
- Applicant
- Medcaptain Life Science Co., Ltd.
- Applicant location
- Shenzhen, CN
- Received
- Feb 27, 2023
- Decided
- Dec 1, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Set, Administration, Intravascular (FPA)
- Device class
- Class II
- Regulation
- 21 CFR 880.5440
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FPA. The earliest in FDA's data is K760103, decided Jul 16, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K230528
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Medcaptain Life Science Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Needle Free Connector510(k)
K213004 · Decided May 10, 2022 · 232 days after receipt
Device type: Set, Administration, Intravascular (FPA) · Hospital Medicine & Nursing
K202578 · Decided May 6, 2021 · 240 days after receipt
Device type: Catheters, Transluminal Coronary Angioplasty, Percutaneous (LOX) · Cardiology
K202619 · Decided Apr 29, 2021 · 231 days after receipt
Device type: Catheters, Transluminal Coronary Angioplasty, Percutaneous (LOX) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.